Close Menu

sequencing-based diagnostics

NEW YORK (GenomeWeb News) – UnitedHealthcare has joined the growing list of national insurers to support non-invasive prenatal diagnostics tests.

NEW YORK (GenomeWeb News) – NewBridge Pharmaceuticals today announced an agreement to offer Verinata Health's non-invasive prenatal tests in the Middle East and surrounding areas.

NEW YORK (GenomeWeb News) – Seeking a share of a market estimated at around $1 billion, GenomeDx plans to launch its first test aimed at prostate cancer during the first half of this year, CEO Doug Dolginow said.

NEW YORK (GenomeWeb News) — Arizona State University's Biodesign Institute today announced a partnership with Life Technologies to develop a gene expression test to rapidly assess an individual's exposure to radiation in the event of a nuclear incident.

NEW YORK (GenomeWeb News) – Silicon Valley Biosystems, a company that provides genomic data at the point of care, has been launched.

NEW YORK (GenomeWeb News) – National managed healthcare company WellPoint has revised its medical policy regarding non-invasive fetal aneuploidy screening, suggesting that it will begin covering tests such as Sequenom's MaterniT21 Plus test.

NEW YORK (GenomeWeb News) – Molecular diagnostics firm DioGenix today announced it has raised $1.5 million in a Series B financing round.
Existing investors including life sciences fund Nerveda participated in the round.

NEW YORK (GenomeWeb News) – Sequenom said Friday evening that it has received notification from the US Patent and Trademark Office that a patent that was scheduled to issue next week has been withdrawn.

NEW YORK (GenomeWeb News) – Microarrays can provide more clinically relevant information than traditional karyotyping, and should become the standard approach in prenatal diagnostics going forward, according to a paper appearing tod

NEW YORK (GenomeWeb News) – The American College of Obstetricians and Gynecologists has issued an opinion that non-invasive prenatal testing using ce

Pages

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.